This controversial decision comes as Kennedy aims to rebuild public trust in vaccinations, highlighting concerns over conflicts of interest within the committee, despite criticisms from health experts who warn of potential repercussions.
RFK Jr. Dismisses Entire Vaccine Advisory Committee Amidst Controversy

RFK Jr. Dismisses Entire Vaccine Advisory Committee Amidst Controversy
In a polarizing move, U.S. Health Secretary Robert F. Kennedy Jr. has terminated all members of the Advisory Committee on Immunization Practices (ACIP), stirring debate on vaccine safety and governance.
U.S. Health Secretary Robert F. Kennedy Jr. has taken a dramatic step by firing all 17 members of the Advisory Committee on Immunization Practices (ACIP), which is tasked with establishing official vaccination recommendations. In an editorial published in the Wall Street Journal, Kennedy justified his actions by citing persistent conflicts of interest that he believes have eroded public confidence in vaccines. He expressed a desire to "ensure the American people receive the safest vaccines possible."
Kennedy's views on vaccines have long been a subject of contention; he has faced significant backlash from physicians and health experts over his skepticism about the safety and efficacy of several vaccines. However, he reassured during his Senate confirmation hearing that he would not strip vaccines from public access. On Monday, he proclaimed his decision to "retire" all members of the ACIP committee, many of whom were appointed in January 2025 as part of President Biden's last-minute appointments.
The ACIP primarily comprises practicing physicians and specialists associated with prominent medical universities, and Kennedy's move raises eyebrows given that it appears at odds with earlier assurances of maintaining the committee without alterations. Republican Senator Bill Cassidy, also a medical doctor, expressed concern about the potential for replacing seasoned experts with individuals who may lack adequate knowledge of vaccines. He subsequently stated on X that he intends to maintain communication with Kennedy to ensure the committee's credibility is not compromised.
In his editorial, Kennedy underscored the need for reform, highlighting that various ACIP members have financial ties to pharmaceutical companies, which he sees as contributing factors to the declining public trust in health authorities and drug manufacturers. Several examples from the 1990s and 2000s were cited, reinforcing his argument about longstanding conflicts of interest.
Dr. Bruce Scott, president of the American Medical Association, criticized Kennedy’s sweeping dismissal as a move that "upends a transparent process that has saved countless lives," especially as vaccination rates drop and measles outbreaks persist. He expressed concern that this action could exacerbate the spread of vaccine-preventable diseases.
The Health Secretary has yet to announce who will fill these vacated positions on the committee. An ACIP meeting is set for late June, during which members are expected to vote on critical vaccine recommendations for various diseases, including COVID-19, flu, and RSV. The Health Department and current ACIP chair Dr. Helen Keipp Talbot have been approached for commentary but have yet to respond.